Literature DB >> 28835942

The Impact of Reduced Injected Radioactivity on Image Quality of Molecular Breast Imaging Tomosynthesis.

Olivia Sullivan1, Zongyi Gong1, Kelly Klanian2, Tushita Patel1, Mark B Williams1,2,3.   

Abstract

This study's objective is to compare image quality in 3-D molecular breast imaging tomosynthesis (MBIT) with that in planar molecular breast imaging (MBI) over a range of breast radioactivity concentrations. Using gelatin and point source phantoms lesion contrast, lesion signal-to-noise ratio (SNR) and spatial resolution were compared for a range of lesion sizes and depths. For both MBI and MBIT, lesion contrast is essentially constant with changing activity while SNR decreases by a factor of 1.5 - 2 between 100% and 25% activity levels. For nearly all lesion sizes and locations contrast and SNR are significantly higher for MBIT than MBI, potentially permitting greater reductions in injected dose. Spatial resolution in MBI is dependent on lesion depth but independent of lesion location with MBIT. Reconstructed MBIT spatial resolution is substantially better than that in the projection images, suggesting future use of higher sensitivity collimators for even further reductions in injected activity.

Entities:  

Keywords:  molecular breast imaging; radiation dose; tomosynthesis

Year:  2012        PMID: 28835942      PMCID: PMC5565232          DOI: 10.1007/978-3-642-31271-7_39

Source DB:  PubMed          Journal:  Breast Imaging (2012)


  6 in total

1.  Dual-modality breast tomosynthesis.

Authors:  Mark B Williams; Patricia G Judy; Spencer Gunn; Stanislaw Majewski
Journal:  Radiology       Date:  2010-04       Impact factor: 11.105

2.  Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts.

Authors:  Deborah J Rhodes; Carrie B Hruska; Stephen W Phillips; Dana H Whaley; Michael K O'Connor
Journal:  Radiology       Date:  2010-11-02       Impact factor: 11.105

3.  Comparison of radiation exposure and associated radiation-induced cancer risks from mammography and molecular imaging of the breast.

Authors:  Michael K O'Connor; Hua Li; Deborah J Rhodes; Carrie B Hruska; Conor B Clancy; Richard J Vetter
Journal:  Med Phys       Date:  2010-12       Impact factor: 4.071

4.  Technetium-99m-sestamibi uptake in breast tumor and associated lymph nodes.

Authors:  J Maublant; M de Latour; D Mestas; A Clemenson; S Charrier; V Feillel; G Le Bouedec; P Kaufmann; J Dauplat; A Veyre
Journal:  J Nucl Med       Date:  1996-06       Impact factor: 10.057

Review 5.  Molecular breast imaging.

Authors:  Michael O'Connor; Deborah Rhodes; Carrie Hruska
Journal:  Expert Rev Anticancer Ther       Date:  2009-08       Impact factor: 4.512

6.  Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging.

Authors:  F J Wackers; D S Berman; J Maddahi; D D Watson; G A Beller; H W Strauss; C A Boucher; M Picard; B L Holman; R Fridrich
Journal:  J Nucl Med       Date:  1989-03       Impact factor: 10.057

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.